SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
8-K	Report of unscheduled material events or corporate event	Mar 22, 2023	View HTML 0001104659-23-035198.pdf 0001104659-23-035198.rtf 0001104659-23-035198.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Feb 28, 2023	View HTML 0001171843-23-001254.pdf 0001171843-23-001254.rtf 0001171843-23-001254.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
10-K	Annual report which provides a comprehensive overview of the company for the past year	Feb 28, 2023	View HTML 0001104659-23-026701.pdf 0001104659-23-026701.rtf 0001104659-23-026701.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
8-K	Report of unscheduled material events or corporate event	Feb 21, 2023	View HTML 0001104659-23-023768.pdf 0001104659-23-023768.rtf 0001104659-23-023768.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
3	Initial filing by director officer or owner of more than ten percent.	Feb 21, 2023	View HTML 0001493152-23-005658.pdf 0001493152-23-005658.rtf 0001493152-23-005658.xls
4	Statement of changes in beneficial ownership of securities	Feb 21, 2023	View HTML 0001493152-23-005663.pdf 0001493152-23-005663.rtf 0001493152-23-005663.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 14, 2023	View HTML 0000902664-23-001725.pdf 0000902664-23-001725.rtf 0000902664-23-001725.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 14, 2023	View HTML 0001140361-23-006807.pdf 0001140361-23-006807.rtf 0001140361-23-006807.xls
SC 13G/A	An amendment to the SC 13G filing	Feb 9, 2023	View HTML 0000315066-23-001436.pdf 0000315066-23-001436.rtf
SC 13G/A	An amendment to the SC 13G filing	Feb 9, 2023	View HTML 0001104659-23-015586.pdf 0001104659-23-015586.rtf

Data provided by Kaleidoscope.